Abstract | OBJECTIVES: DESIGN: A literature review was conducted, searching the Medline and PubMed database from 1966 to 2009, using the terms ' otosclerosis' and ' fluoride'. Article abstracts were reviewed and relevant full articles acquired. RESULTS: There has been only one double-blind, placebo-controlled trial of the use of sodium fluoride in otosclerosis patients, and this found a reduced incidence of deterioration in hearing after two years in the treatment group. Several case-control series have described a hearing benefit in the sodium fluoride treated group. Treatment doses vary greatly, and there is no evidence regarding the optimum duration of treatment. CONCLUSIONS: There is low quality evidence suggesting that sodium fluoride may be of benefit to preserve hearing and reduce vestibular symptoms in patients with otosclerosis.
|
Authors | A S Cruise, A Singh, R E Quiney |
Journal | The Journal of laryngology and otology
(J Laryngol Otol)
Vol. 124
Issue 6
Pg. 583-6
(Jun 2010)
ISSN: 1748-5460 [Electronic] England |
PMID | 20163750
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Animals
- Hearing Loss
(prevention & control)
- Humans
- Otosclerosis
(diagnosis, drug therapy)
- Sodium Fluoride
(therapeutic use)
- Tomography, X-Ray Computed
|